ÂÜÀòÂÒÂ×

Hassan Bruneo is a seasoned professional with extensive experience in market access, pricing, and policy within the pharmaceutical and healthcare sectors. Currently serving as Vice President and Head of EU Market Access at Krystal Biotech, Inc. since August 2022, Hassan has previously held leadership roles at Alnylam Pharmaceuticals, Biogen, Simon-Kucher & Partners, Ernst & Young, and KPMG. Notable positions include Head of Market Access for the CEMEA region at Alnylam and Senior Manager for Global Market Access at Biogen. Hassan's academic credentials include degrees in Biomedical Engineering and Management Engineering from Politecnico di Milano.